Ascendis Investigational Site

Cincinnati, Ohio 45229

2 studies enrolling now · 3 studies all time

What they study most

Growth Hormone Deficiency, Head and Neck Neoplasms

Studies at this site

• A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA — Recruiting now
• A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin — Recruiting now
• TransCon (TC) TLR7/8 Agonist, TC IL-2 β/γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma — Stopped early